# Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days

> **NCT00791388** · PHASE1 · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** PG-760564
- **DRUG:** PG-760564
- **DRUG:** PG-760564
- **DRUG:** PG-760564

## Key facts

- **NCT ID:** NCT00791388
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2011-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791388, "Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00791388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*